Conag, Mylen .

HRN: 19-27-04  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2024
CEFUROXIME 1.5GM (VIAL)
03/15/2024
03/15/2024
IVT
1.5gms
Now Then Q 8 Hrs
WBC 23.0
Waiting Final Action 
03/15/2024
CEFUROXIME 1.5GM (VIAL)
03/15/2024
03/15/2024
IVT
1.5gms
Now Then Q 8 Hrs
WBC 23.0
Waiting Final Action 
03/15/2024
CEFUROXIME 1.5GM (VIAL)
03/15/2024
03/15/2024
IVT
1.5gms
Now Then Q 8 Hrs
WBC 23.0
Waiting Final Action 
03/16/2024
CEFTRIAXONE 1G (VIAL)
03/16/2024
03/23/2024
IV
2g
OD
UTI
Waiting Final Action 
03/16/2024
METRONIDAZOLE 500MG (TAB)
03/16/2024
03/23/2024
PO
500
TId
Thicky Msaf
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: